An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting

NCT06148935 · clinicaltrials.gov ↗

RECRUITING

Status

1350

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure With Reduced Ejection Fraction

Interventions

DRUG: Vericiguat (Verquvo, BAY1021189)

Sponsor

Bayer